EnClear Therapies
Cambridge, MA
EnClear Therapies is a Cambridge (USA) based life sciences company developing a device-based therapy to aid in the treatment of neurodegenerative disease and delivery and monitoring of cerebrospinal fluid (CSF). EnClear’s proprietary therapeutic platform focuses on removing toxic proteins from the C... Read more
encleartherapies.comCompany Details
Founded
- 2018
Employees
- Between 5 - 20 employees
Raised
- $17,718,332
Headquarters Location
- Cambridge, MA
Public
- No
Acquired
- No
CEO
Anthony DePasqua
Founders
- Anthony DePasquaManuel N.Kevin Eggan
Company Collections
These are collections EnClear Therapies is a part of. Click on the collection name to view similar companies.
EnClear Therapies' Investors
EnClear Therapies' Industries
EnClear Therapies' Tech Stack
EnClear Therapies Headquarters Location
700 Main Street North., Cambridge, MA 02139
Total Amount Raised: $17,718,332
EnClear Therapies' Investors
EnClear Therapies Funding Rounds
Grant
$5,000,000
Grant Investors
National Cancer Institute (NCI)National Institute of Neurological Disorders and Stroke (NINDS)Series Unknown
$718,331
Series A
$10,000,000
Series A Investors
20/20 HealthCare PartnersGlobal Health Sciences Venture FundPeter ThielThiel CapitalPresight CapitalAmgenDolby Family VenturesQuark VentureTachyon VenturesBiovergeSeed
$2,000,000
Seed Investors
Presight CapitalThiel CapitalBiovergeSanford BiosciencesVU Venture PartnersMichael Ströck
Funding info provided by Diffbot.
EnClear Therapies Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on EnClear Therapies.